Founded in April 2025, the company was born from the founders desire to create an innovative platform driven by a clear missionto make high-quality care simple to start and easy to maintain
Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, et al
Our formula is gluten-free and non-GMO, making it an exceptional choice for serious men and women athletes everywhere
Methodological Quality and Risk of Bias Assessment We used the Cochrane Risk of Bias 2 (RoB 2) tool (crossover extension where applicable) for assessing the risk of bias to evaluate the methodological quality of RCTs
Tanshinone IIA activates nuclear factor-erythroid 2-related factor 2 to restrain pulmonary fibrosis via regulation of redox homeostasis and glutaminolysis
Fat Metabolism : GIP can reduce circulating triglycerides when used therapeutically